Toggle navigation
Menu
About Us
Investment Strategy
Team
Portfolio
News
Contact Us
Limited Partners
News
EyePoint Pharmaceuticals Receives FDA Approval of YUTIQ (fluocinolone acetonide intravitreal implant) 0.18 mg
Oct 15 2018
Recent News
VitalConnect Secures over $30 Million in Oversubscribed Series F Financing
Grundium Oy Announces the Appointment of Head of the US Business and Two Independent Board Members
EW Healthcare Partners Announces Platform Investment in Enercon Technologies
Frost & Sullivan Recognizes VitalConnect with the 2022 New Product Innovation Award for Its Leading-edge Wearable Patient Monitoring Device
BioTissue Completes Name Change
Related: Team
Ron Eastman
Related: Portfolio